BEIJING, July 31, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading cancer hospital operations management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China, today announced that Concord Medical signed a cooperation agreement with Peking University International Hospital.
Under the cooperation agreement, Concord Medical will provide comprehensive services for the Department of Radiotherapy and Nuclear Medicine of Peking University International Hospital. Peking University International Hospital is a hospital affiliated to Peking University Medical School and has a good reputation in the medical industry. It has a total construction area of 440,000 square meters with 1,800 beds. As the first U.S. listed medical service company in China, Concord Medical is experienced in providing radiation therapy and diagnosis imaging services, and provides patients with the advanced technical standards, quality control procedures and multidisciplinary treatments of the top cancer treatment institutions in the United States. Through this cooperation, both parties will develop their respective advantages and strive to provide quality multidisciplinary medical services for patients in Beijing and the surrounding areas.
About Concord Medical
Concord Medical Services Holdings Limited is a cancer hospital management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China. As of December 31, 2017, the Company operated a network of 44 centers with 30 hospital partners that spanned 29 cities and 18 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For more information, please contact:
Concord Medical Services Mr. Ting JIA (Chinese and English) +86 10 5957 5270 [email protected]
Advertisement
Under the cooperation agreement, Concord Medical will provide comprehensive services for the Department of Radiotherapy and Nuclear Medicine of Peking University International Hospital. Peking University International Hospital is a hospital affiliated to Peking University Medical School and has a good reputation in the medical industry. It has a total construction area of 440,000 square meters with 1,800 beds. As the first U.S. listed medical service company in China, Concord Medical is experienced in providing radiation therapy and diagnosis imaging services, and provides patients with the advanced technical standards, quality control procedures and multidisciplinary treatments of the top cancer treatment institutions in the United States. Through this cooperation, both parties will develop their respective advantages and strive to provide quality multidisciplinary medical services for patients in Beijing and the surrounding areas.
Advertisement
About Concord Medical
Concord Medical Services Holdings Limited is a cancer hospital management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China. As of December 31, 2017, the Company operated a network of 44 centers with 30 hospital partners that spanned 29 cities and 18 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For more information, please contact:
Concord Medical Services Mr. Ting JIA (Chinese and English) +86 10 5957 5270 [email protected]
View original content:http://www.prnewswire.com/news-releases/concord-medical-announces-the-signing-of-cooperation-agreement-with-peking-university-international-hospital-300688974.html
SOURCE Concord Medical Services Holdings Limited
